Junshi Biosciences Announces Phase 3 Study of Toripalimab Combined with Bevacizumab for the First-line Treatment of Advanced Hepatocellular Carcinoma Meets Primary Endpoint
Globe Newswire12-06-2024, 09:06
Fortinet Joins the Joint Cyber Defense Collaborative (JCDC) to Continue Strengthening U.S. Cybersecurity Resiliency 18-04-2023, 20:00